Probe Gold Vs. Cidara Therapeutics Industry Stock Comparison

Buy

54

PROBF
Probe Gold

Last Price:

$1.65

Seasonality Move:

16.47%

Buy

69

CDTX
Cidara Therapeutics

Last Price:

$61.65

Seasonality Move:

2.01%

Buy

54

Probe Gold (PROBF) is a Buy

Is Probe Gold a Buy, Sell or Hold?

The current Probe Gold [PROBF] share price is $1.63. The Score for PROBF is 54, which is 8% above its historic median score of 50, and infers lower risk than normal.
PROBF is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

Buy

69

Cidara Therapeutics (CDTX) is a Buy

Is Cidara Therapeutics a Buy, Sell or Hold?

The current Cidara Therapeutics [CDTX] share price is $61.99. The Score for CDTX is 69, which is 38% above its historic median score of 50, and infers lower risk than normal.
CDTX is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

PROBF Stock Price Chart

What is Probe Gold's stock price today?

The Probe Gold share price today is $1.63

Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and PROBF is experiencing selling pressure, which indicates risk of future bearish movement.

CDTX Stock Price Chart

What is Cidara Therapeutics's stock price today?

The Cidara Therapeutics share price today is $61.99

Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CDTX is experiencing slight buying pressure.

PROBF Technical Analysis

Chart Indicators	Level	Buy or Sell
MACD (12, 26):	0.45	Buy
Relative Strength Index (14 RSI):	48.23	Sell
Chaikin Money Flow:	-17404	-

Bollinger Bands	Level	Buy or Sell
Bollinger Bands (25):	(1.59 - 1.69)	Sell
Bollinger Bands (100):	(1.39 - 1.73)	Buy

CDTX Technical Analysis

Chart Indicators	Level	Buy or Sell
MACD (12, 26):	16.99	Buy
Relative Strength Index (14 RSI):	66.48	Buy
Chaikin Money Flow:	174751	-

Bollinger Bands	Level	Buy or Sell
Bollinger Bands (25):	(51.47 - 62.93)	Buy
Bollinger Bands (100):	(16.15 - 48.57)	Buy

PROBF Moving Averages

Moving Averages	Level	Buy or Sell
8-day SMA:	1.61	Buy
20-day SMA:	1.64	Sell
50-day SMA:	1.7	Sell
200-day SMA:	1.4	Buy
8-day EMA:	1.4	Buy
20-day EMA:	0.89	Buy
50-day EMA:	0.44	Buy
200-day EMA:	0.12	Buy

CDTX Moving Averages

Moving Averages	Level	Buy or Sell
8-day SMA:	62.35	Sell
20-day SMA:	59.18	Buy
50-day SMA:	43.75	Buy
200-day SMA:	26.07	Buy
8-day EMA:	51.53	Buy
20-day EMA:	31.38	Buy
50-day EMA:	15.22	Buy
200-day EMA:	4.21	Buy

Probe Gold Earnings Growth & PROBF Earnings Dates

Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Cidara Therapeutics Earnings Growth & CDTX Earnings Dates

Analysts estimate an earnings increase this quarter of $3.83 per share, a decrease next quarter of $0.00 per share, an increase this year of $15.94 per share, and a decrease next year of $0.39 per share.

Probe Gold Technical Analysis

	Jul 23	Jul 24	Jul 25	Jul 29	Jul 30	Jul 31	Aug 1	Aug 4	Aug 5	Aug 6
	Jul							Aug
	23	24	25	29	30	31	01	04	05	06
Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Cidara Therapeutics Technical Analysis

	Jul 24	Jul 25	Jul 28	Jul 29	Jul 30	Jul 31	Aug 1	Aug 4	Aug 5	Aug 6
	Jul							Aug
	24	25	28	29	30	31	01	04	05	06
Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):